Gilead Earnings Top Views; Biotech Giant Narrows Guidance

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 30, 2021 at 11:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Gilead stock edged lower late Thursday after the biotech company reported adjusted earnings of $1.87 per share on $6.217 billion in second-quarter sales.

    article source